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The ontogeny of mammalian cell-mediated immune responsiveness is critically
dependent upon the specialized maturational microenvironment of the thymus.
The initial event heralding the lymphoid development of the thymus occurs (in
the mouse) at approximately the eleventh day of gestation, when lymphoid stem
cells, apparently derived from the yolk sac or fetal liver, migrate into the largely
epithelial thymic anlage (1, 2). These lymphoid stem cells establish an intrinsic
thymic pool of precursor cells with limited self-renewing potential; the lymphoid
cells of the thymus are maintained throughout adult life due to a continual low-
level seeding of the thymus by precursor cells of extrathymic (mostly bone mar-
row) origin (3). Much attention has been devoted to characterizing the bone
marrow-derived T cell precursors, since at least some congenital abnormalities
in cell-mediated immune function are thought to result from defects within this
population of bone marrow cells (4). Further, isolation of bone marrow-derived
T cell precursors may prove to be clinically important in repopulating the thymic
lineages of cells after viral-, radiation-, or chemically induced immuno-
deficiencies.
We have previously identified and isolated a small fraction (0.1-0.3%) of
mouse bone marrow cells that contains pluripotent hematopoietic stem cells (5).
This population of stem cells expresses low levels of the Thy-1 antigen (Thy-1'°)
and lacks expression of surface markers that characterize cells within defined
differentiated hematolymphoid cell lineages (Thy-1'° Lin-). Elsewhere, we have
shown that this population contains B cell precursors and myeloid/erythroid
precursor activity (5). The isolated fraction of cells was able to rescue lethally
irradiated mice and repopulate the thymus and peripheral T cell populations (6).
This experiment implies, but does not prove, that the putative stem cell fraction
is able to home to the thymus and repopulate the T cell lineage. Therefore, we
sought to quantitate T cell precursor activity within the bone marrow by using
a quantitative limiting dilution assay of thymic homing. We report here that the
Thy-1"' Lin- bone marrow fraction contains thymus-homing T cell precursors at
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a level that is 50-80-fold enriched over unseparated bone marrow cells. A sec-
ond fraction of mouse bone marrow, which is also Thy-1'° but expresses at least
one other hematolymphoid lineage marker (Thy-1" Lin+), is present as 1-5% of
the nucleated cells and contains a twofold enrichment of thymic repopulating
activity. These two fractions can account for at least half of the thymic
repopulating activity in the bone marrow.
Materials and Methods
Mice. C57BL/Ka (Thy-1 .2, Ly1 .2, Ly5.1), C57BL/6-a17-Lyl .l (B/6-Lyl.l ; Thyl .2,
Lyl.l, Ly5.1), and C57BL/Ka-Thy-1 .1 (BA; Thy-1 .1, Ly1 .2, Ly5.1) were bred and main-
tained in our animal facility. C57BL/6J-Ly5.2: Pep-36 (B/6-Ly5.2; Thy-1 .2, Lyl .2, Ly5.2)
breeding pairs were kindly provided by Dr. E. A. Boyse (Memorial Sloan Kettering Can-
cer Center, NY, NY) and thereafter were bred and maintained in our animal facility.
Antibodies. Mouse mAbs 19XE5 (anti-Thy-1 .1), obtained from Dr. R. Nowinski
(Genetic System Inc., Seattle, WA), and A20.1 (anti-Ly5.2) and 104.2 (anti-Ly5 .1),
obtained from Dr. E. A. Boyse, were purified by affinity chromatography on immoblized
protein A and were derivatized with fluorescein or biotin by standard techniques. Mouse
mAb MAR-18 (anti-rat K light chain) and rat mAbs 53-2.1 (anti-Thy 1 .2), M1/70.15.11 .5
(anti-Mac-1), GK1 .5 (anti-CD4), and 53-6.72 (anti-CD-8) were obtained from the Amer-
ican Type Culture Collection, Rockville, MD. Rat mAbs RB6-8C5 (anti-Gr-1, a granulo-
cyte marker) and RA3-6B2 (anti-B220), were obtained from Dr. R. Coffman (DNAX,
Stanford, CA) (7,8). Rat mAbs were concentrated for fluorescein or biotin conjugation
by ammonium sulfate precipitation or membrane filter concentration of serum-free cul-
ture supernatants.
Multiparameter Cell Sorting.
￿
The dual laser FACS used in these experiments was mod-
ified from a Becton Dickinson & Co. (Mountain View, CA) machine as described (9). This
instrument and supporting computer hardware and software were made available
through the FACS-shared users group at Stanford University, Stanford, CA.
Preparation of Bone Marrow Suspensions.
￿
Fresh bone marrow cells were isolated by
flushing femora from 3-wk-old mice with HBSS containing 5% FCS and lOmM Hepes
buffer Suspensions to be separated by FACS were reacted with fluoresceinated anti-Thy-
1 .1 or anti-Thy-1 .2 antibodies together with a cocktail of biotinylated rat mAbs specific
for mouse differentiation antigens Gr-1, Mac-1, B220, CD4, and CD8 (see above for
antibody designations). After a wash in HBSS through a cushion of FCS, the cells were
reacted with Texas red-coupled avidin (Cappel Laboratories, Cochranville, PA). After a
second wash, the cells were resuspended for FACS separation. Debris, erythrocytes,
doublets, and dead cells were excluded by forward scatter and propidium iodide gating.
Thymic Repopulation Assay.
￿
The limiting dilution method of Ezine et al. (10) was used
to detect thymic-homing T cell precursors. Briefly, normal 4-8-wk-old male or female
C57BL6/Ka mice were irradiated (700 rad at 100 rad/min from a Phillips 250 Kv x-ray
machine). The animals were reconstituted 3-24 h later with an intravenous transfer of
2.5 X 106 bone marrow cells of syngeneic origin. In addition, unseparated or FACS-
isolated fractions of bone marrow from congenic mice were included in the intravenous
transfer. The transferred bone marrow cells differentiate in vivo to give rise to popula-
tions of thymocytes and mature T cells, within which can be detected the progeny of the
congenic population by mAbs specific for the allelic cell surface marker. If the congenic
population of bone marrow cells is present at limiting dilution, only a fraction of the
reconstituted animals will contain progeny from that population. Each clonogenic cell
gives rise to a colony, or focus, of donor-derived cells in the thymus (10).
The recipient animals were killed 5-6 wk after reconstitution and analyzed by either
immunohistochemical techniques or by two-color FACS for the presence of T cells
derived from the donor strains, based on the expression of the relevant allele. In all
cases, the thymus and peripheral lymph nodes were analyzed. Animals with significant
populations (>O.1% of the cells analyzed) of donor-derived cells in thymus or lymphSPANGRUDE ET AL .
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FIGURE 1 . Detection of
donor-derived cells by FAGS
analysis . Thymocytes from
two radiation chimeras that
received intrathymic injec-
tions of Thy-l'° Lin- cells
sorted from a Thy-1 .1 con-
genic donor 4 wk earlier were
stained for the Thy-1 .1 allele .
Fluorescent events are scored
as positive cells only if they
fall within the fluorescent
intensity and forward plus
right angle scatter windows
defined by control positive
cells . (A) A typical negative animal in which no positive cells were detected in 50,000 events (B) The
threshold of detection as 15 positive cells in 50,000 events (0.03%) . In practice, animals are consid-
ered positive when donor-derived cells comprise 0.1% of the organ . Therefore, in a typical thymic
lobe containing 5 X 10 7 cells, the threshold clone size is 5 X 10' cells. Logarithmic contour plots
have been used to facilitate visualization of the rare population of donor cells (9) FAGS analysis of
lymph node suspensions is equally sensitive (data not shown) .
nodes were scored as positive . For two-color FAGS analysis, biotinylated anti-Thy-1 .1,
anti-Lyl .l, and anti-Ly 5.2 antibodies were detected with Texas red-avidin (Cooper
Biomedical, Inc ., Westchester, PA) and unconjugated anti-CD4 and anti-CD8 antibodies
were detected with a fluoresceinated mouse anti-rat K light chain mAb (MAR-18 .5) . Neg-
ative animals and syngeneic controls typically contained 0-0.02% of total cells that
stained above background levels . Thus, the 0 .1% threshold is at least fivefold above neg-
ative control staining (Fig. 1) . In addition to the number of positive animals in each
group, the range of percentage of donor-derived cells in thymus or lymph nodes is
reported .
Intrathymic injections of bone marrow or bone marrow fractions were performed
under ether or ketamine/xylazine anesthesia (11) . Mice were irradiated (700-800 rad)
within 3 h before surgery . The indicated number of cells were injected into one thymic
lobe of each recipient mouse in a volume of 5 jl . Animals were killed 3-4 wk after injec-
tion and a cell suspension was prepared from each thymic lobe . The suspensions were
stained and analyzed as above .
We have proposed the term "thymic colony-forming unit" (CFU t)' to denote the bone
marrow cells that give rise to the thymic colonies (12) . This nomenclature leaves open
the question of whether the colonies are the products of committed thymocyte progen-
itors (prothymocytes, pre-T cells) or of pluripotent hematopoietic stem cells . Thymus-
homing CFU, denote these progenitors of thymic colonies that appear after intravenous,
as opposed to intrathymic, transfer of bone marrow cells .
Results
It is known that the bone marrow contains cells capable of homing to and
repopulating the thymus of irradiated animals (13) . To characterize the cells
within the bone marrow that express this thymus homing CFUt activity, clono-
genic thymus-homing bone marrow cells were enumerated as previously
described (10) after FACS isolation of defined bone marrow subsets . Fig. 2
shows a representative contour plot obtained by staining a suspension of bone
marrow cells for expression of Thy-1 in the fluorescein dimension and for
1 Abbreviations used in this japer: CFU splenic CFU ; CFU thymic CFU .1674
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Bone marrow cell
suspension staining for isola-
tion of hematopoietic stem
cells . Fresh bone marrow cells
were isolated from 3-wk-old
C57B1/Ka-Thy-1 .1 (BA)
mice . Cell staining was per-
formed as described in Mate-
rials and Methods . (A) The
four fractions of cells (I-IV)
contained the following per-
centages of the total popula-
tion : 1, 76% ; 11, 20% ; III, 3%;
IV, 0.3% . Solid lines indicate
background levels of staining.
(B) The cells contained in
fraction IV express roughly 10-fold lower levels of the Thy-1 antigen than do mature T lymphocytes,
which are visualized as the isolated population in A, fraction III. B was generated during the col-
lection of Thy-l" cells, and as such reflects only the sorting windows, not the purity, of the popu-
lations. Upon reanalysis, Thy-l" Lin- cells collected by cell sorting were at least 60% pure, with the
contaminating cells being derived mostly from fraction If. Note that they Thy-1"' Lin' cells excluded
mature T lymphocytes, which are the Thy-l" Lin' population in fraction 111 .
expression of any of five hematolymphoid lineage-specific differentiation mark-
ers (see Materials and Methods for details) in the Texas red dimension . The four
populations thus defined have been numbered according to the percentage of
the total bone marrow population that is contributed by each fraction . The least
abundant fraction (Fig. 2 IV) contains bone marrow cells that express low levels
of the Thy-1 antigen, but lack antigens associated with mature T cells, B-lineage
cells, granulocytes, and macrophages (Thy-1" Lin-) . As is shown in Fig . 2, Thy-
I "' Lin- cells (IV) express -10-fold less Thy-1 antigen than thymocytes or
mature lymphocytes (III) . The Thy-1 '° Lin- fraction of bone marrow, which con-
tributes only 0.1-0.3% to the total number of resident bone marrow cells, con-
tains pluripotent hematopoietic stem cells, since low numbers (50-200 cells) res-
cue and reconstitute fully all compartments of the hematolymphoid system of
lethally irradiated hosts (6) .
Do Thy-l'" Lin- bone marrow cells include clonogenic, thymus-homing CFU,?
The data shown in Table I summarize the results of four independent experi-
ments . The cotransfer of various number of congenic bone marrow cells with
2 .5 X 106 syngeneic unseparated bone marrow cells into irradiated recipient
mice results in congenic-derived thymic colonies in some of the animals . The
fraction of positive animals is directly dependent upon the number of congenic
haplotype cells that are transferred . Application of limiting dilution statistics to
the unseparated bone marrow data reveals that one thymus-homing CFU, is
engrafted when 3.4 X 104 congenic bone marrow cells are cotransferred with
2.5 X 106 syngeneic bone marrow cells, with a coefficient of correlation r =
-0.98 . Thymus-homing CFU, activity was enormously enriched when FAGS-iso-
lated Thy-1"" Lin- bone marrow cells were transferred (Table I) . Individual
thymic clones were observed when only 100-250 Thy-l'" Lin- cells from con-
genic donors were included in the reconstituting population . This enrichment is
comparable to the ^-100-200-fold increase in pre-B and CFU activities in the
Thy-I"' Lin - fraction when compared with unfractionated bone marrow (5) .SPANGRUDE ET AL.
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TABLE I
Enrichment of T Cell Precursors by Cell Sorting
Groups of irradiated animals received the indicated number of congenic cells along with 2.5 X I Ofi
syngeneic bone marrow cells in one intravenous transfer. 6 wk later, the animals were killed and
analyzed immunohistochemically or by FACS for the presence of donor-derived (Thy-1 .1) T cells.
*The percentage of donor cells was not determined in groups analyzed by immunohistochemical
staining.
While the greatest enrichment of detectable thymus-homing CFUt in bone
marrow was contained in the Thy-1'° Lin- population, some activity was also
found in the bone marrow population that coexpresses Thy-1 and at least one
of the determinants detected by the cocktail of antibodies specific for other mat-
urational markers (Thy-1'° Lin +, Table I). The enrichment does not approach
that seen in the Thy-V° Lin- fraction when compared with unseparated bone
marrow, and is not due to mature bone marrow T cells (Thy-l hi CD4+ and/or
CD8+). Finally, the data in Table I show that the fraction of bone marrow that
lacks expression of either Thy-1 or any of the maturation-associated determi-
nants (Thy-1 - Lin-) also lacks thymus-horning CFU, activity. Thus, the greatest
enrichment of bone marrow cells capable of homing to and differentiating
within the thymus was contained in the 0.1-0 .3% of bone marrow with the phe-
notype Thy-1'° Lin-, while an equivalent amount of CFU, activity was found at
a 10-fold lower enrichment in the Thy-1'°+, Lin+ fraction.
The data in Table I demonstrate a 50-100-fold enrichment of thymus-seeding
clonogenic CFUt in the Thy-1'" Lin - population . Approximately 1 in 600 of
these cells produced a clonal thymic repopulation after intravenous injection, as
compared to 1 in 34,000 unseparated bone marrow cells. It is possible that an
even higher proportion of the Thy-1'" Lin- cells can respond to the thymic
microenvironment, since only a fraction of the Thy-1'" Lin- cells placed in the
bloodstream were likely to seed to the thymus.
To evaluate critically the absolute frequency of CFU, contained within the
Cell population
Number of cells
transferred
Positive
animals/total
Percent of donor-derived
cells mean (range)
Unseparated bone marrow 5.0 X 104 18/24 ND*
2.5 X 104 8/14 1 .5% (0.1-1 .5)
1 .7 X 104 5/16 ND
8.3 X 10" 3/19 ND
Thy-1'°, Lin- 2.5 X 10" 6/6 ND
1 .4 X 10" 5/5 ND
2 .5 X 101 3/9 0.5% (0.1-1 .2)
1 .8 X 101 2/5 ND
1 .0 X 102 1/3 0.5
Thy-1'", Lin+ 2 .5 X 10" 4/4 3.7% (0.2-11 .8)
1 .4 X 10" 1/5 ND
1 .8 X 101 0/5
Thy-1'" CD4+ and/or CD8+ 5.0 X 10" 0/3
Thy-1 -, Lin - 1 .0 X 104 0/4
2.5 X 10" 0/6
2.5 X 101 0/61676
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0.95), IT, 1/2600 (r = -0.96). The following
data points are not shown on these plots: 1,000 Thy-I'° Lin- cells IV, 0% negative animals (8/8+),
400 Thy-1'° Lin- cells IT, 0% negative animals (9/9 +), 104 Thy-1'° Lin+ cells IV, 56% negative
animals (4/9+), 2,500 Thy-11" Lin+ cells IT, 33% negative animals (6/9+). The limiting dilution sta-
tistics include only the latter two of these four data points.
Frequencies can also be estimated by interpolating to the X intercept of 37% negative animals.
By this method, the frequencies are: bone marrow IV, 1/39,000, IT, 1/8,400. Thy-1° Lin- IV, 1/
670, IT, 1/100. Thy-1'° Lin+ IV, 1/17,000, IT, 1/2100.
Thy-lf° Lin- and Thy-1" Lin+ fractions, the populations were isolated for direct
intrathymic injections. This technique has previously been used to examine
thymic progenitor cells (14-17). To compare the thymic cloning efficiencies of
both fractions with whole bone marrow by both intrathymic and intravenous
routes of injection, the following experiment was designed. Two groups, each
consisting of 40 C57BL/Ka mice (Thy1 .2, Ly1.2, Ly5.1) served as recipients.
For intravenous transfers, mice were irradiated (900 rad, 24 h before reconsti-
tution) and reconstituted with 2.5 X 106 syngeneic bone marrow cells plus
titrated amounts of whole bone marrow from B/6-Ly1.1 donors (Thy1.2, Ly1 .1,
Ly5.1 ; 8 X 109-5 X 104 cells), Thy-I" Lin- cells from BA donors (Thyl.l,
Lyl.2, Ly5.2 ; 150-1,000 cells), and Thy-1'° Lin+ cells from B/6-Ly5.2 donors
(Thyl.2, Ly1.2, Ly5.2 ; 800-5,000 cells). For intrathymic transfers, mice were
irradiated (800 rad, 3 h before reconstitution) and reconstituted with 106 syn-
geneic bone marrow cells intravenously. The intrathymically injected cell sus-
pensions consisted of a reciprocal titration of syngeneic and B/6-Lyl.l bone
marrow, such that each thymus received 5 X 104 bone marrow cells with a titra-
tion of congenic marrow in the range of 5 X 109-2 X 104 cells. In addition,
the suspensions contained titrations of BA-derived Thy-11° Lin- cells (50-300
cells) and B/6-Ly5.2-derived Thy-I" Lin+ cells (40-500 cells). This experimental
design provides that nearly identical numbers of cells are injected into each ani-
mal. Each dose of cells in each titration was injected into eight recipient animals.
FIGURE 4.
￿
Detectionof donor-derived cells by immunohistochemical analysis. Thymus tissue
was analyzed 4 wk after intrathymic injection of 50 FACS-isolated Thy-1'° Lin- cells (BA
origin) and 4 X 105 unseparated bone marrow cells (B/6-Ly-5.2 origin) into one thymic lobe
of an irradiated (650 rad) C57BL/Ka mouse. The figure shows serial sections stained with
anti-Thy-1 .1 (A) or anti-Ly-5.2 (B). The uninjected thymic lobe is negative for both stains,
while the injected lobe contains progeny of both injected populations. (4X) .SPANGRUDE ET AL.
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Recipient animals were killed 4 wk after intrathymic injection and 5 wk after
intravenous injection. Suspensions of thymocytes were screened by FRCS for
progeny of each donor population, based on expression of the unique allotypic
cells surface markers. The results were tabulated as the number of animals in
each group that contained progeny of a particular transferred population and
are presented as a limiting dilution analysis in Fig. 3. The estimated frequencies
of CFUt activity in each fraction as shown in the figure are based on the negative
inverse of the slope of each line. The estimates by interpolation to the 37% neg-
ative point are indicated in the legend to Fig. 3. The best-fit lines and coeffi-
cients of correlation (r) were calculated by least-squares linear regression anal-
ysis. The results indicate that whole bone marrow, Thy-1'" Lin-, and Thy-1")
Lin+ cells all exhibit a 7-8-fold enhancement of thymic-cloning efficiency when
the cell transfer is intrathymic compared with intravenous. The average clone
sizes in millions of cells per thymus ranged from 1.1 to 9.8 for intrathymic trans-
fer, and from 2.4 to 20.8 for intravenous transfer. The frequency of CFU, was
calculated from the slopes as 1/90 Thy-1" Lin- cells, 1/2,600 Thy-P) Lin+ cells,
and 1/5,100 bone marrow cells by intrathymic transfer. Thus, in this experi-
ment, thymic clone-forming cells were enriched -60-fold in the Thy-I'" Lin-
fraction.
It is of interest to note that only a fraction (1/90) of the Thy-1") Lin- cells
produced thymic colonies after intrathymic injection. It is plausible that in the
absence of other bone marrow cells, the thymus is incapable of supporting the
survival of many of the directly injected Thy-11" Lin- cells. This was tested by
mixing 50 FACS-isolated Thy-1") Lin- cells derived from BA mice (Thy-1 .1,
LY5.1) with 4 X 105 unseparated bone marrow derived from B/6-Ly5.2 mice
(Thy-1 .2, Ly5.2) and injecting the mixture intrathymically into C57BL/Ka mice
(Thy-1 .2, Ly5.1). With this experimental design. the unfractionated bone mar-
row cells might provide the necessary microenvironment and promote better
survival of the isolated Thy-11" Lin- cells after intrathymic transfer. In addition,
the B/6-Ly5.2 bone marrow serves as an internal control for the efficiency of
the intrathymic injections. The results showed that although nine of nine exper-
imental animals had large populations (5-10%) of Ly5.2+ cells in the injected
thymic lobe, only three of nine animals had detectable levels of Thy-1.1 + thy-
mocytes (Fig. 4) . This data is in good agreement with that shown in Fig. 3, indi-
cating that the coinjected bone marrow did not contribute significantly to the
survival of the injected Thy-1"" Lin- cells.
Discussion
The Thy-1 antigen is not readily detectable on non-T cells in normal mouse
bone marrow by conventional methods. Mouse bone marrow contains ^-5% T
cells as determined by immunofluorescence using antibodies specific for Thy-1,
CD4, and CD8 (5, 18). Early attempts to eliminate myeloid/erythroid precursors
(19) or T cell precursors (20) by treating mouse bone marrow with anti-Thy-1
antibodies and complement failed, indicating that hematolymphoid precursors
in the mouse do not express high levels of Thy-1. Recently, however, Thy-1 has
been detected on a variety of hematopoietic precursors in mouse bone marrow.SPANGRUDE ET AL.
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Basch and Berman (21) demonstrated Thy-1 on thymus-homing T cell precur-
sors, and on late (and to a lesser extent on early) myeloid/erythroid precursors,
as detected in the CFU assay. They showed that T cell precursors and CFU could
be eliminated by anti-Thy-1 antibodies and complement, and CFU could be
enriched by FACS. However, they used a highly amplified staining system that
indicated Thy-1 expression on 25-30% of mouse bone marrow, including
mature B cells and eosinophils. Therefore, this system precluded appreciable
enrichment. In a similar amplified staining system, Thy-1 has also been reported
to be present on myeloid/erythroid and high proliferative macrophage precur-
sor cells that give rise to in vitro colonies upon stimulation with supernatant
derived from mitogen-stimulated spleen cells (22) . Complement-mediated cyto-
toxicity was used to demonstrate Thy-1 expression on murine erythroid and
myeloid progenitors (23) .
We have recently described the isolation of Thy-l-expressing hematopoietic
stem cells that completely repopulated the hematolymphoid system of lethally
irradiated hosts (5). In our laboratory, Thy-1 is found on only 3-6% of mouse
bone marrow cells, with the Thy'° Lin- cells contained within 0.1-0 .3% of the
total population. Thus, we can localize the pluripotent hematopoietic stem cell
activity within a very small fraction of mouse bone marrow cells and demon-
strate that the precursors of B lymphocytes and myeloid/erythroid lineages (5)
and T lymphocytes (this study) are all highly enriched within one fraction of
mouse bone marrow.
The frequency of clonogenic CFU, cells in unfractionated bone marrow is
quite low (^-1 /3 .3 X 104) in the intravenous limiting dilution assay, ^-10-fold
lower than the frequency of thymus-homing bone marrow cells which upon thy-
mus entry express T cell differentiation markers (20) . In contrast, the frequency
reported here is at least fivefold higher than that of others (15, 16). This dis-
crepancy is most likely due to a higher inherent cloning efficiency afforded by
the true limiting dilution approach used in the present experiments (see refer-
ence 12 for a discussion). It is this discrepancy that is responsible for our esti-
mate of the thymic homing efficiency as a factor of 7-8 as compared with 25-
50 in other studies (15, 16), since our frequency estimate of CFU, by intrathymic
transfer of whole bone marrow is in good agreement with that obtained by other
investigators (Tatsuo Kina, Stanford University, Stanford, CA, personal
communication).
A low and variable amount of enrichment for CFU, has been observed in the
Thy-1'° Lin+ fraction of bone marrow, which might suggest that the activity in
this fraction is a result of inefficient FACS separation. More recent experiments
(to be reported separately) tend not to support this interpretation, as the Thy-
I" Lin+ fraction has now been subdivided into three populations, only one of
which possesses thymic-homing CFU, activity (Heimfeld et al., manuscript in
preparation). The Thy-1" Lin- population used in these experiments is almost
certainly contaminated with Thy-1" Lin+ cells, which are in hematopoietic lin-
eages for which we have no markers (e .g., erythroid and megakaryocytic) .
Recently, the Thy-1" Lin- fraction has been subdivided into two populations
based on staining with a newly derived mAb (E13 161-7, see reference 24), and
CFU, activity as well as pluripotent hematopoietic stem cell activity are solely1680
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contained in one of these two populations (Spangrude et al., manuscript in
preparation). These observations tend not to support the suggestion that inef-
ficient FACS separation is responsible for the CFUt activity in the Thy-1" Lin+
fraction of bone marrow.
Based on the frequency analysis shown in Fig. 3, one can calculate the per-
centage of bone marrow CFU, activity that can be accounted for by the two
FACS-isolated fractions. Using the frequency estimates given by the 37% inter-
cepts (Fig. 3, legend), whole bone marrow contains 12 CFUt/105 cells injected
intrathymically. The Thy-l" Lin- fraction, comprising 0.25% of the total bone
marrow, contains 1 CFU,/100 cells and thus contributes 2.5 CFU,/105 bone
marrow cells. Correction of this number to compensate for the purity of the
sorted fraction as measured by reanalysis (5, 6) allows an estimate of 4.2 CFU,/
105 bone marrow cells being contributed by the Thy-1" Lin- fraction. A similar
calculation for the Thy-1'° Lin+ fraction, which comprised 4.6% of the total
bone marrow in the experiment shown in Fig. 3, results in an estimate of 2.2
CFUt/105 bone marrow cells being derived from this fraction, with no correc-
tion for the purity of the sorted fraction. Thus, by a very conservative estimate,
which assumes that cellular functions and potentials in the sorted fractions are
unaffected by a 4-5h staining and cell-sorting regimen, one can account for
over half of the CFU, activity in whole bone marrow as being recovered in the
two Thy-1" fractions. In addition, some CFUt activity was detected by intra-
thymic transfer of the cells in bone marrow fraction II (as defined in Fig. 2),
but this activity was less than that in unseparated bone marrow (data not shown)
and failed to home to the thymus (Table 1).
It has been a generally accepted concept that the pluripotent hematopoietic
stem cell in the bone marrow makes a commitment to the lymphoid lineage (25)
or even to the T lymphoid lineage (26, 27) before homing to the thymus, where
further differentiation occurs . Cloned bone marrow cell lines have been
described (28) that have the properties of progenitor cells that are committed
to the T lineage. Although Mulder et al. (29) have presented evidence support-
ing the existence of bone marrow pre-T activity, which by kinetic analysis is due
to a more mature progenitor than the pluripotent hematopoietic stem cells, they
failed to demonstrate whether this population of cells is solely committed to
differentiation along the T lineage. Both fractions of bone marrow characterized
herein, as well as subsequent subfractions of those populations identified by
expression of combinations of antigenic determinants, contain CFU, only in the
presence of self-renewing pluripotent hematopoietic stem cells (contained in the
Thy-1" Lin- fraction) or of precursors of multiple lineages (contained in
the Thy-1t° Line" fraction) (data not shown). Whether committed bone marrow
prothymocytes can be separated from multipotent precursors by cell-sorting
methods remains to be elucidated. Alternatively, the final committment to mat-
uration along the T lineage may occur only after a multipotent progenitor cell
enters the thymus. According to the latter view, hypothesized by Moore and
Owen (30), the only true prothymocytes will reside solely within the thymus.
The maturational development of a functional immune system is of consid-
erable interest, in both experimental and clinical applications. It is important to
define the process of immune maturation in ontogeny as well as in the recoverySPANGRUDE ET AL.
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of the immune system from radiation, from chemotherapy of malignancies, and
from immunosuppressive viral diseases such as AIDS. Further, insight into
immune maturation can help define specific lesions in the processes that result
in various genetically acquired or congenital immune deficiencies. Finally, the
isolation of highly enriched, and perhaps pure populations of hematopoietic
stem cells shown in this and previous communications (6, 31), should be valuable
for bone marrow allotransplantation, for gene transfection experiments, and
ultimately, for a complete understanding of the process of hematolymphoid
development.
Summary
Two-color FACS analysis of mouse bone marrow reveals a rare population,
comprising 0.1-0.3% of the total, that expresses low levels of the Thy-1 antigen
but does not express any of five surface markers that characterize differentiated
hematolymphoid cells. We demonstrate here that this fraction of mouse bone
marrow is enormously enriched in cells that can home to the thymus and dif-
ferentiate into mature T lymphocytes, subsequently migrating to peripheral lym-
phoid organs. Only a subset of the FACS-isolated fraction (1/90 after intra-
thymic injection) is capable of responding to the thymic microenvironment with
a productive commitment to the T cell lineage. A second fraction of mouse bone
marrow, which expresses how levels of Thy-1 but is also positive for at least one
of five hematolymphoid lineage-specific markers, also contains cells that home
to the thymus and establish colonies of thymocytes. The two fractions each con-
tribute approximately equal amounts of thymic colony-forming units (CFU,) to
the bone marrow, and together can account for at least half of the CFUt in
whole bone marrow.
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